ArticlePostepy psychiatrii neurologii2024
MoodMon: novel optimization of bipolar disorder monitoring through patient-driven voice parameter submission and AI technology.
Article in Postepy psychiatrii neurologii, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Behavioral data collected from smartphones can assist artificial intelligence (AI) in assessing and predicting fluctuations in mental states in patients with bipolar disorder (BD). In Poland, the MoodMon online system is used to integrate passive and active data, including voice parameters, for analysis and the issue of alerts based on changes in individual's mental state. The study aims to explore whether active engagement of the patient enhances the efficacy of the advanced MoodMon tool. This clinical trial is embedded in a broader research initiative. Methods: Methodologically, smartphones were used to automatically collect daily activity data from wristbands and phones of 75 BD patients. Clinical evaluations, using the Hamilton Depression and Young Mania Rating Scales were conducted via a web app, regular visits, calls, or system-initiated contacts after alerts. The MoodMon system, trained on patient data, was compared against clinical evaluations, successfully predicting mental states. Results: Results showed high alert accuracy: true positive ratio (TPR) at 86.6% (sensitivity) and true negative ratio (TNR) at 98.59% (specificity). Active patient voice data submissions notably improved the prediction of changes or stability in mental states. Conclusions: Active patient participation in data submission enhances MoodMon's effectiveness as an AI-driven monitoring tool for BD. This underscores the potential of behavioral markers and mobile health applications in mental health care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.